Literature DB >> 24922269

Synthesis of the Pitstop family of clathrin inhibitors.

Mark J Robertson1, Fiona M Deane1, Wiebke Stahlschmidt2, Lisa von Kleist2, Volker Haucke2, Phillip J Robinson3, Adam McCluskey4.   

Abstract

This protocol describes the synthesis of two classes of clathrin inhibitors, Pitstop 1 and Pitstop 2, along with two inactive analogs that can be used as negative controls (Pitstop inactive controls, Pitnot-2 and Pitnot-2-100). Pitstop-induced inhibition of clathrin TD function acutely interferes with clathrin-mediated endocytosis (CME), synaptic vesicle recycling and cellular entry of HIV, whereas clathrin-independent internalization pathways and secretory traffic proceed unperturbed; these reagents can, therefore, be used to investigate clathrin function, and they have potential pharmacological applications. Pitstop 1 is synthesized in two steps: sulfonation of 1,8-naphthalic anhydride and subsequent reaction with 4-amino(methyl)aniline. Pitnot-1 results from the reaction of 4-amino(methyl)aniline with commercially available 4-sulfo-1,8-naphthalic anhydride potassium salt. Reaction of 1-naphthalene sulfonyl chloride with pseudothiohydantoin followed by condensation with 4-bromobenzaldehyde yields Pitstop 2. The synthesis of the inactive control commences with the condensation of 4-bromobenzaldehyde with the rhodanine core. Thioketone methylation and displacement with 1-napthylamine affords the target compound. Although Pitstop 1-series compounds are not cell permeable, they can be used in biochemical assays or be introduced into cells via microinjection. The Pitstop 2-series compounds are cell permeable. The synthesis of these compounds does not require specialist equipment and can be completed in 3-4 d. Microwave irradiation can be used to reduce the synthesis time. The synthesis of the Pitstop 2 family is easily adaptable to enable the synthesis of related compounds such as Pitstop 2-100 and Pitnot-2-100. The procedures are also simple, efficient and amenable to scale-up, enabling cost-effective in-house synthesis for users of these inhibitor classes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24922269     DOI: 10.1038/nprot.2014.106

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  51 in total

1.  Functional analysis of interaction sites on the N-terminal domain of clathrin heavy chain.

Authors:  Anna K Willox; Stephen J Royle
Journal:  Traffic       Date:  2011-10-20       Impact factor: 6.215

2.  An endophilin-dynamin complex promotes budding of clathrin-coated vesicles during synaptic vesicle recycling.

Authors:  Anna Sundborger; Cynthia Soderblom; Olga Vorontsova; Emma Evergren; Jenny E Hinshaw; Oleg Shupliakov
Journal:  J Cell Sci       Date:  2011-01-01       Impact factor: 5.285

3.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

4.  Internalization of proprotein convertase PC7 from plasma membrane is mediated by a novel motif.

Authors:  Jeroen Declercq; Sandra Meulemans; Evelyn Plets; John W M Creemers
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

5.  Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization.

Authors:  Eiji Goto; Yuko Yamanaka; Akiyo Ishikawa; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mari Ohmura-Hoshino; Yohei Matsuki; Mizuho Kajikawa; Hisashi Hirano; Satoshi Ishido
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

6.  Development of 1,8-naphthalimides as clathrin inhibitors.

Authors:  Kylie A MacGregor; Mark J Robertson; Kelly A Young; Lisa von Kleist; Wiebke Stahlschmidt; Ainslie Whiting; Ngoc Chau; Phillip J Robinson; Volker Haucke; Adam McCluskey
Journal:  J Med Chem       Date:  2013-12-18       Impact factor: 7.446

7.  Invasive and adherent bacterial pathogens co-Opt host clathrin for infection.

Authors:  Esteban Veiga; Julian A Guttman; Matteo Bonazzi; Emmanuel Boucrot; Alejandro Toledo-Arana; Ann E Lin; Jost Enninga; Javier Pizarro-Cerdá; B Brett Finlay; Tomas Kirchhausen; Pascale Cossart
Journal:  Cell Host Microbe       Date:  2007-11-15       Impact factor: 21.023

8.  The first five seconds in the life of a clathrin-coated pit.

Authors:  Emanuele Cocucci; François Aguet; Steeve Boulant; Tom Kirchhausen
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

9.  Clathrin is required for the function of the mitotic spindle.

Authors:  Stephen J Royle; Nicholas A Bright; Leon Lagnado
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

10.  Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells.

Authors:  Charlotte M Smith; Volker Haucke; Adam McCluskey; Phillip J Robinson; Megan Chircop
Journal:  Mol Cancer       Date:  2013-01-17       Impact factor: 27.401

View more
  14 in total

1.  Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.

Authors:  Rebecca E Yarwood; Wendy L Imlach; TinaMarie Lieu; Nicholas A Veldhuis; Dane D Jensen; Carmen Klein Herenbrink; Luigi Aurelio; Zhijian Cai; MacDonald J Christie; Daniel P Poole; Christopher J H Porter; Peter McLean; Gareth A Hicks; Pierangelo Geppetti; Michelle L Halls; Meritxell Canals; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

2.  Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.

Authors:  Daniel P Poole; TinaMarie Lieu; Juan Carlos Pelayo; Emily M Eriksson; Nicholas A Veldhuis; Nigel W Bunnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

3.  Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.

Authors:  Josue Jaramillo-Polanco; Cintya Lopez-Lopez; Yang Yu; Emma Neary; Alan Hegron; Meritxell Canals; Nigel W Bunnett; David E Reed; Alan E Lomax; Stephen J Vanner
Journal:  J Neurosci       Date:  2022-03-07       Impact factor: 6.709

4.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.

Authors:  Dane D Jensen; TinaMarie Lieu; Michelle L Halls; Nicholas A Veldhuis; Wendy L Imlach; Quynh N Mai; Daniel P Poole; Tim Quach; Luigi Aurelio; Joshua Conner; Carmen Klein Herenbrink; Nicholas Barlow; Jamie S Simpson; Martin J Scanlon; Bimbil Graham; Adam McCluskey; Phillip J Robinson; Virginie Escriou; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Gareth A Hicks; Macdonald J Christie; Christopher J H Porter; Meritxell Canals; Nigel W Bunnett
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

5.  Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.

Authors:  Nestor N Jimenez-Vargas; Luke A Pattison; Peishen Zhao; TinaMarie Lieu; Rocco Latorre; Dane D Jensen; Joel Castro; Luigi Aurelio; Giang T Le; Bernard Flynn; Carmen Klein Herenbrink; Holly R Yeatman; Laura Edgington-Mitchell; Christopher J H Porter; Michelle L Halls; Meritxell Canals; Nicholas A Veldhuis; Daniel P Poole; Peter McLean; Gareth A Hicks; Nicole Scheff; Elyssa Chen; Aditi Bhattacharya; Brian L Schmidt; Stuart M Brierley; Stephen J Vanner; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

6.  Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.

Authors:  Nestor N Jimenez-Vargas; Jing Gong; Matthew J Wisdom; Dane D Jensen; Rocco Latorre; Alan Hegron; Shavonne Teng; Jesse J DiCello; Pradeep Rajasekhar; Nicholas A Veldhuis; Simona E Carbone; Yang Yu; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Meritxell Canals; David E Reed; Alan E Lomax; Brian L Schmidt; Kam W Leong; Stephen J Vanner; Michelle L Halls; Nigel W Bunnett; Daniel P Poole
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-16       Impact factor: 11.205

7.  Toxoplasma gondii Mechanisms of Entry Into Host Cells.

Authors:  Juliana Portes; Emile Barrias; Renata Travassos; Márcia Attias; Wanderley de Souza
Journal:  Front Cell Infect Microbiol       Date:  2020-06-30       Impact factor: 5.293

Review 8.  Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches.

Authors:  Punit Saraon; Shivanthy Pathmanathan; Jamie Snider; Anna Lyakisheva; Victoria Wong; Igor Stagljar
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

9.  Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages.

Authors:  Shigeyasu Tsuda; Masakazu Shinohara; Toshihiko Oshita; Manabu Nagao; Nobuaki Tanaka; Takeshige Mori; Tetsuya Hara; Yasuhiro Irino; Ryuji Toh; Tatsuro Ishida; Ken-Ichi Hirata
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

10.  A novel naphthalimide that selectively targets breast cancer via the arylhydrocarbon receptor pathway.

Authors:  J Gilbert; G N De Iuliis; A McCluskey; J A Sakoff
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.